Free Trial

Cytek Biosciences (CTKB) Competitors

Cytek Biosciences logo
$3.36 -0.02 (-0.45%)
As of 11:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CTKB vs. TXG, TRNS, EYPT, ALNT, LAB, AEHR, SENS, QSI, QTRX, and MASS

Should you be buying Cytek Biosciences stock or one of its competitors? The main competitors of Cytek Biosciences include 10x Genomics (TXG), Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Aehr Test Systems (AEHR), Senseonics (SENS), Quantum-Si (QSI), Quanterix (QTRX), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

Cytek Biosciences vs. Its Competitors

10x Genomics (NASDAQ:TXG) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

In the previous week, 10x Genomics had 6 more articles in the media than Cytek Biosciences. MarketBeat recorded 7 mentions for 10x Genomics and 1 mentions for Cytek Biosciences. 10x Genomics' average media sentiment score of 0.63 beat Cytek Biosciences' score of 0.00 indicating that 10x Genomics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
10x Genomics
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cytek Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cytek Biosciences has lower revenue, but higher earnings than 10x Genomics. Cytek Biosciences is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
10x Genomics$610.78M2.74-$182.63M-$1.30-10.45
Cytek Biosciences$200.45M2.12-$6.02M-$0.09-37.28

10x Genomics has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500.

84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 9.4% of 10x Genomics shares are held by insiders. Comparatively, 10.3% of Cytek Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cytek Biosciences has a net margin of -5.71% compared to 10x Genomics' net margin of -25.14%. Cytek Biosciences' return on equity of -2.90% beat 10x Genomics' return on equity.

Company Net Margins Return on Equity Return on Assets
10x Genomics-25.14% -23.22% -18.02%
Cytek Biosciences -5.71%-2.90%-2.30%

10x Genomics presently has a consensus price target of $13.23, suggesting a potential downside of 2.62%. Cytek Biosciences has a consensus price target of $5.60, suggesting a potential upside of 66.92%. Given Cytek Biosciences' higher probable upside, analysts plainly believe Cytek Biosciences is more favorable than 10x Genomics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
10x Genomics
1 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.42
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

10x Genomics beats Cytek Biosciences on 9 of the 16 factors compared between the two stocks.

Get Cytek Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTKB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTKB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTKB vs. The Competition

MetricCytek BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$426.21M$3.07B$5.69B$9.49B
Dividend YieldN/A2.44%4.05%3.99%
P/E Ratio-37.3821.0428.0020.03
Price / Sales2.12251.99397.6083.98
Price / Cash93.6541.9636.1958.45
Price / Book1.098.268.655.83
Net Income-$6.02M-$55.19M$3.24B$258.39M
7 Day Performance1.67%5.52%3.62%2.50%
1 Month Performance3.87%18.20%11.16%12.85%
1 Year Performance-46.58%7.33%35.16%21.38%

Cytek Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTKB
Cytek Biosciences
2.5624 of 5 stars
$3.36
-0.4%
$5.60
+66.9%
-45.9%$426.21M$200.45M-37.38500News Coverage
Gap Down
TXG
10x Genomics
4.1217 of 5 stars
$12.47
-2.6%
$14.13
+13.3%
-28.2%$1.54B$624.66M-9.591,240Analyst Revision
TRNS
Transcat
2.4264 of 5 stars
$86.45
-0.2%
$112.20
+29.8%
-42.0%$805.71M$278.42M55.421,245News Coverage
EYPT
Eyepoint Pharmaceuticals
1.2338 of 5 stars
$10.17
-1.8%
$25.67
+152.4%
+11.9%$699.81M$56.04M-4.22120
ALNT
Allient
1.7146 of 5 stars
$39.11
+1.3%
$31.00
-20.7%
+41.2%$662.09M$516.06M66.292,525
LAB
Standard BioTools
3.6289 of 5 stars
$1.25
-5.3%
$2.50
+100.0%
-36.1%$474.78M$169.69M-3.57620Positive News
Upcoming Earnings
AEHR
Aehr Test Systems
1.9519 of 5 stars
$13.86
-1.8%
$25.00
+80.4%
+22.8%$412.61M$58.97M-106.6190
SENS
Senseonics
2.3666 of 5 stars
$0.49
-0.8%
$1.70
+244.9%
+22.8%$322.46M$23.68M-3.7990Positive News
QSI
Quantum-Si
1.9411 of 5 stars
$1.73
flat
$3.48
+100.9%
+66.4%$317.45M$3.44M-2.54150Gap Up
QTRX
Quanterix
2.7379 of 5 stars
$6.05
+2.7%
$13.50
+123.1%
-62.6%$302.20M$137.42M-4.65460Analyst Revision
MASS
908 Devices
1.3786 of 5 stars
$6.72
-3.2%
$5.33
-20.6%
+31.4%$240.98M$59.63M-12.4460Positive News

Related Companies and Tools


This page (NASDAQ:CTKB) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners